Ledger.Open graph →

SEC Form D · Amendment · filed February 18, 2025

Vergent Bioscience, Inc

Offering

$5.0M

Sold

$3.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

MINNEAPOLIS, MN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Samuel Dean Banks · Minneapolis, MNDirector Douglas T. Kohrs · Minneapolis, MNDirector Ryan Egeland · Minneapolis, MNDirector Jeffrey T. Yurecko · Minneapolis, MNExec Bobby T. Helmedag · Minneapolis, MNDirector John Santini · Minneapolis, MNExec · Director Raymond T. Wong · Minneapolis, MNDirector Jeff Julkowski · Minneapolis, MNDirector Anita T. Watkins · Minneapolis, MNDirector Jeffrey T. Yurecko · Minneapolis, MNExec Jeff Julkowski · Minneapolis, MNDirector Douglas T. Kohrs · Minneapolis, MNDirector Anita T. Watkins · Minneapolis, MNDirector John Santini · Minneapolis, MNExec · Director Raymond T. Wong · Minneapolis, MNDirector Ryan Egeland · Minneapolis, MNDirector Samuel Dean Banks · Minneapolis, MNDirector Bobby T. Helmedag · Minneapolis, MNDirector Michael Jordan · New York, NYDirector Nancy T. Chang · Malvern, PADirector J. M. Sorensen · Malvern, PADirector Andrew Rigby · Holladay, UTExec Kevin R. Lokay · Malvern, PAExec · Director Michael R. Friedman · Malvern, PADirector Lawrence M. Alleva · Malvern, PADirector Don Braun · Dallas, TXDirector Joel M. Sussman · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗